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I-rc,ln >larch 1%2 to -4pril 1966, 118 patients were treated a i th  renal 
~ ~ ~ ; , ~ ~ ] ~ l ; ~ n t a t i o n ,  3 with kidneys from identical twins, 9 aith cadaveric 
i,o1310gl.nfts, and 108 with homografts from volunteer donors. Sixty-two 
of the patients are still alive after nine months to almost five years. 
Tllc only completely satisfactory group was that of the identical twin 
rt.cil\ients. 
The results after homotransplantation hare not materially improved 
,luring tllis time despite the a c ~ ~ u i i t i o n  f increased experience, adjust- 
I I ~ ,  llts of timing and dosage of azathioprine and prednisone, and attempts 
idt,ntify biologically suitable donors in advance of operation by tissue 
:!.ping. It. is suggested that an impasse has been reached, beyond which 
further reduction in mortality and morbidity will depend primarily upon 
tltc rti'ectire application of new immunosuppressi,ire techniques. 
~.:~.ri.:!~:r techniques for donor selection with the hope of thereby reducing r, 
t h i  need for these drugs. i ! - .  In this report, we will suggest that an impasse has been reached, imposed 
la!' the inherent limitations of the agents used t o  control rejection. A survey 
011: own esperience has shown that the acquisition of increased experience, I 
' I  - 
:i.. 1:-.-~itution of variations in therapy, and even the application of antigen , !  
1 - 
&! l'ir.2 nlrthods for donol. selection have not eliminated or even significantly 5 
hdut-id the nlorbidity and mortality after transplantation. The cases can 
iw. di~iclcd into four groups. , 
i 
I; 
I 
'. , ! 
111 +te of the increasing acceptance during the last five years of renal 
t.o!:iu:r;insplontat.ion as a legitimate clinical undertaking, those responsible 
it*: r!.. rare of such patients have been keenly aware of the imperfections of 
ti.. ri:ir:~peutic techniques employed during this time. Investigators in 
- :.t 7 : : :  rrnters including our own have tried to  vary systematically the timing 
x . 1 :  Co-:igc of the two most important immunosuppressive agents, azathio- 
isr::.; ::::11 prednisone. Furthermore, efforts have been made to apply antigen- 
! 
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All three patients had glomerulonephritis. They were 27, 20, and 54 yea 
old when their operations n-ere performed 58, 42, and 9 mont,hs ago. Each no. 
has normal renal function although the patient with the lo~igest follow-u 
has had persistent n~icroecopic he~iiaturia for almost five years. A biopsy i. 
the second case after two years was normal. 
FIRST LII'IXG DONOR SERIES 
These 64 patients were operated upon from 34 to 50 lnol~tlis ago. F o ~ t y - ~ i )  
received kidneys from family menlbers (20 parents, 23 siblings, and 3 aunts 
uncles, or cousins) ; the other 18 donors were nonrelated. No other egon 
was made to match donor-recipient pairs than, with a few exceptions, to ensure 
against ABO blood group incompatibilities. The first 45 patients were treated 
solely with azathioprine until rejection developed, a t  which time prednirone 
was added. The last 19 received b0t.h drugs from the beginning. Actinomycin 
C and local homograft irradiation were used irregularly. 
Thirty-two of the patients are still alive. The sur~iva l  of the recipients of 
related kidneys is 29 of 46 (63%). In  contrast, only three of the 18 patients 
in the nonrelated group (16.7%) remain alive (Fig. l ) ,  one by virtue of 
a second graft after 2% years. 
The change in the timing of prednisone admjnistrat.ion in the second part 
of the series did not result in an  increase in the total amount. of this drug 
which nas given. By using large quantities of steroids fro111 the beginning, 
the incidence of seyere early rejections was reduced, making i t  possible to 
attenuate dosage a t  a more rapid rate. The consequent balancing effect is 
shown in Figure 2 in which the average dose per day for the first 105 days 
was found to be almost identical for the recipients of related homografts in 
both the earlier and later groups who lived this long; analysis of the nonrelated 
cases revealed the same thing. 
During the acquisition of the series, there was a trend to conservatism in 
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FIGURE I. Survival in the first series of 64 patients treated with homografts from living 
donors. -411 patienb are alive beyond the points indicated by the vertical arrows. Follow-up 
is thus 34 to 50 months. 
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LIVING DONOR SERIES 
105 ONS I 101 DAYS AZATHlWRlNE W I C  
lmgm/kg/dayl 
F ~ ( ~ c R E  ?. Analysis oi doses of immunosuppression in the two fractions of the first and 
,,, tl,,. *cond xriee oi l~on~otrans~~l:~ntations from living related donors. Tllc division of the 
fir-1 group \vap on rhe basis of differences in the administration of steroids; the first pa- 
1,.-111; ( a r rrceivrti Prrdnisone for t he specific indication of rejection and the later patients 
t 1,) rcvr~\.ed this drug propl~ylactically from the time of operation. The data are from the 
tir-1 105 postopernti~e days; patients who failed to live this long were esrluded. The influ- 
~11t.c  oi tliese changes on the white cell counts and creatinine clearance is shown. 
illr use of azathioprine t Fig. 2) which reflected growing apprehension about 
~ h c  acute bone marrow depression which was then a common complication. 
.In expected corollary change was an increase in the white cell counts (Fig. 
? I .  
Xvel.age renal iunction, illustrated in terms of creatinine clearance was 
.lightly better in the second group of patients n-ho were treated from the 
I~c.:inlii~i_r with prednisone (Fig. 2) but the difference was not statistically 
si:~~ificant. 
Studies of these original cases provided hope tha t  future results could be 
improved using white cell antigen matching in donor selection. Thirty-seven 
of tlie original 64 patients who survived for a t  least one year were typed by 
Tcrn*nki along with their respective donors. I t  was found that the best 
rli~~ical results tentled to I)e in those cases with a high degree of donor- 
rc.ripient compatibility of lymphocyte antigens. Furthermore, there was a 
very firm correlation between the completeness of this matching and the 
r~llnlity of preservation in the homograft biopsies studied at about two years 
121. 
SECOSD LIVING DOSOR SERIES 
These 42 p a t i w e  received homografts 9 to 27 months ago from volunteers 
"110 were chosen insofar as possible on the basis of the best available 
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TIME IN MONTHS 
F I C ~ R E  3. Survi\.al in the first year follolvinp homotmnsl~lantation in the second living 
donor wries. The patients included have been follo\r-ed from 12 to 27 months. One of the 
nonreluted group subsequently died after 17 months. 
antigen inatch. In 25 cases, there were related donors (15 parents, 9 siblinga, 
1 uncle). Because the selectivity within mosb families was limited, the 
quality of matching was only slightly (and not significantly) better thm 
could have been achieved with random intrafan~ilial pairing; the donor pool 
for the 17 nonrelated cases was a large one allowing much greater discrimina- 
tion (91. Imlnunosuppression was similar to that in the previous series except 
- 
that prednisone was usually started in relatively snlall doses on the day of 
operation and later increased if iequired for control of rejection. 
Twenty-five of the patients are still alive. I i  of 25 (68%) in the related 
and 8 of 17 (47%) in the unrelated groups. The statistics for the first 36 
cases, all operated upon 12 months or longer ago are shown for the first 
year in Figure 3. The s u m i ~ a l  after one year was slightly worse in the related 
cases (63.1%) than in the original series, but it was better (53%) in the 
The previously described tendency to use smaller doses of azathioprine, 
which had already been noted during the treatment of the original series, 
of patients, continued (Fig. 2) into the last group.; Now, however, the 
penalty became the need to use higher maintenance doses of prednisone; the 
data shown are from the related cases, but analysis of 'the nonrelated trans- 
plantations revealed exactly the same'thing. In spite of this adjustment the. 
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,,,:,l,l,j,lc ]c~aranrcs during t11c first. 105 days was distinctly poorel* t p  < 0.05,) 
, , 1 f i r  series (Fig. 21. The incidence of acute f:~ilul.e from drug 
,,,,,,.ity lI:Ic] thus been greatly reduced but a t  the expense of lcss adequate 
,,.,it protection, a delayed lllortality which is apt to bc a t  least as 
t . l ! l l d l ' - .  : 
,,,, :;. :,. i l l  rile original series since several of the patients still living are not 
-. 
:,,:!.,. ,,.,.11. :II,,I ill1 u~~qucstionshly incrcasrd long-term nlorbidity. 
, ~ l ~ l l l ~ j ~ s ~  of scven of thesc hol~logrnfts were obtained a t  al~prosin~atcly two 
?;01,p \vcrc normal tilid only two \yere free of more or less serious 
.tr,,l.tur:~l a1)normalities. 
C-ADAVERIC SERIES 
- r ~ , ~ ~ . ~  l.cripicnts, ~)~.ovitlcd wit11 cadaveric homogl.afts in 1963. died within 
4 39 cl:~y.s: with unrelicvcd uremia. In the last 10 to 14 molitl~a, six lnore 
.:I!.:::.:. :,ttc.mpt+ 1vel.e m:rdc; :ill of the kidneys functiolled following delays 
,,i 10 llliilutcs to 23 days after revascularization. Four of these recipients died 
~,irl.!. 3 8. 10, and 12% ~llollths with failing grafts and with selltic coil~plica- 
ll,,l,. of tlle kind described in the preceding section. An additional patient 
11:irl normal function for the first seven months had a late uncontrolled 
r,.,c.~.rion and is awaiting homograft removal and retransplantation. The 
f i l l : r I  1):ltient is one year postoperative with normal renal function. 
DISCUSSIOS 
'ri,(. iorcgoing obser\rations make it clear that, if renal homotra~lsplantation 
I,:,. Ib(.,,olne a standard form of therapy for terminal renal disease, it has 
:tc.llic.vc*tl this status prematurely. Every active transplantation center has its 
I~r. i l l i : t l l t  results, but the incidence of failure is high and, what is worse, it 
-V~.IIIS to have reached an irreducible minimum employing the "standard" im- 
rr~~~tlo+uppressive ag nts. In  our own institutions, tlie progressively more timid 
11-t. oi azathioprine, combined with altered programs of prednisone adminis- 
tr:triul~. 112s virtually eliminated the early postoperative deaths from acute 
11(111t. 111:1rr01v clepres~ion, but a t  the expense of later diminished function and 
:I IIIC!!~.~ ultimate steroid need in many cases. The eventual mortality has 
n.l~l::il:cli ~*elat i~ely fixed with each such adjustment in management. 
I [  i -  cclunlly discouraging to note that the use of prospective antigen 
111:11rIiiiig for donor selection did not have more influence upon prognosis. 
Titi$ was not surprising in the consanguineous transplantations since selec- 
t l~ i t y  could- not be significantly improved due to the problem of supply. 
This was not the situation. however, in the nonrelated cases where the one-year 
'llr\.i1.:11 was upgraded by only 20%, reaching the still unsatisfactory figure 
5 3 5 .  The latter finding emphasizes the futility, with the presently avail- 
:ll1l(' tllcrapeutic protocols, of envisioning effective and large scale application 
ofti+ut, typing techniques in cadaver programs. 
TI11> does not imply either that the tissue typing methods now being 
""\'~.lol'(~d are not a direct or indirect measure of histocompatibility factors, 
Or 'll:it the use of these techniques will play an insignificant role in trans- 
~'l:llltatioa practices of the future. Indeed, evidence has been cited earlier 
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to the degree of antigen nonconformity between donors and recipients. 
fair trial with the treatment programs now widely being used unless trans. 
plantation is performed only between allnost perfectly matched pairs or, 
alternatively, that they require for exploitation a setting of far more adequate' 
immunosuppression. The former approach would limit consideration to au 
but a very small number of patients who need this kind of therapy. ~ b t  
latter development would allow extension rather than restriction of the 
indications for acceptance into a transplantation program. Investigations 
new methods of immunosuppression, reported elsewhere in this ~ y m p o s i u ~ ,  
provide hope this object i~e can be realized. 
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